2019
DOI: 10.1021/acs.oprd.9b00023
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Scalable Synthesis for the Potent Kinase Inhibitor BMS-986236; 1-(5-(4-(3-Hydroxy-3-methylbutyl)-1H-1,2,3-triazol-1-yl)-4-(isopropylamino)pyridin-2-yl)-1H-pyrazolo[3,4-b]pyridine-5-carbonitrile

Abstract: Development of a Scalable Synthesis for the Potent Kinase Inhibitor BMS-986236; 1-(5-(4-(3-Hydroxy-3-methylbutyl)-1H-1,2,3-triazol-1yl)-4-(isopropylamino)pyridin-2-yl)-1H-pyrazolo[3,4-b]pyridine-5carbonitrile

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…In contrast to the material in entry 9, this material is ranked as either Low Hazard or Medium Hazard, depending on the scale. Scientists at Bristol Myers Squibb (BMS) reported the use of 5-azido-2-chloro- N -isopropylpyridin-4-amine (entry 11) in the synthesis of a kinase inhibitor . Although no ARC or explosivity data were provided in the article, this tool would have highlighted the need for such testing.…”
Section: Applying the Oreos Methodsmentioning
confidence: 99%
“…In contrast to the material in entry 9, this material is ranked as either Low Hazard or Medium Hazard, depending on the scale. Scientists at Bristol Myers Squibb (BMS) reported the use of 5-azido-2-chloro- N -isopropylpyridin-4-amine (entry 11) in the synthesis of a kinase inhibitor . Although no ARC or explosivity data were provided in the article, this tool would have highlighted the need for such testing.…”
Section: Applying the Oreos Methodsmentioning
confidence: 99%
“…Indeed, a 53% yield of the 5,6-fused heterocycle 3p was obtained in one step from commercial starting materials (Scheme 3). Finally, a tangible application of this reaction in the preparation of an intermediate leading to the IRAK4 inhibitor BMS-986236 23 was examined to highlight the advantages of this azide-free method (Scheme 4). The first-generation synthesis of BMS-986236 used an energetic azide intermediate, necessitating a second-generation synthesis for scale-up that used a less-energetic hetaryl azide.…”
Section: Letter Syn Lettmentioning
confidence: 99%